RESUMO
Autoimmune thyroiditis (AIT) and type 2 diabetes mellitus (DM2) are the most common endocrinological diseases worldwide. Relation between these diseases explains several hypotheses. One of them is influence of some adipocytokines. This study evaluated association between three adipocytokines (adiponectin, resistin and visfatin) and thyroid and glycid status in patients with DM2 and AIT compared to the control group (CG). The group consisted of four subgroups: patients with DM2 without thyreopathies, patients with AIT on substitution therapy without diabetes and prediabetes, patients with DM2 and AIT on substitution therapy and healthy subjects as the CG. We investigated parameters of thyroid and glucose metabolism and serum levels of three adipocytokines. The mean level of resistin in the group of patients with diabetes and thyroiditis was significantly higher than in patients with thyroiditis without diabetes and than in the CG. We found a weak negative correlation between visfatin and fasting glucose levels in patients with thyroiditis without diabetes. We detected a weak negative correlation between resistin and glycated haemoglobin and a weak negative correlation between visfatin and thyroid gland volume in patients with diabetes without thyroiditis. In the CG we determined a weak positive correlation between visfatin and free thyroxin. Our results are consistent with several studies, which confirmed association between AIT and adipocytokines.
Assuntos
Adipocinas/sangue , Citocinas/sangue , Diabetes Mellitus Tipo 2/sangue , Nicotinamida Fosforribosiltransferase/sangue , Glândula Tireoide/diagnóstico por imagem , Tireoidite Autoimune/sangue , Adulto , Idoso , Estudos de Casos e Controles , Diabetes Mellitus Tipo 2/complicações , Feminino , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Tireoidite Autoimune/complicações , Tireoidite Autoimune/diagnóstico por imagem , Ultrassonografia , Adulto JovemRESUMO
Gliptins act by increasing endogenous incretin levels. Glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic peptide receptor (GIPR) are their indirect drug targets. Variants of GLP1R and GIPR have previously been associated with the incretin effect. The aim of the present pilot study was to examine associations of the GLP1R and GIPR gene variants with the glycaemic response to gliptins. A total of 140 consecutive patients with type 2 diabetes were followed-up 6 months after initiation of gliptin treatment. GLP1R rs6923761 (Gly168Ser) and GIPR rs10423928 genotyping was performed using real-time PCR, with subsequent high-resolution melting analysis. The main study outcome was reduction in glycated haemoglobin (HbA1c) after treatment. GLP1R Gly168Ser variant was significantly associated with reduction in HbA1c in an additive model (ß = -0.33, p = 0.011). The mean reduction in HbA1c in Ser/Ser homozygotes was significantly lower compared with Gly-allele carriers [0.12 ± 0.23% vs. 0.80 ± 0.09% (1.3 ± 2.5 mmol/mol vs. 8.7 ± 1.0 mmol/mol); p = 0.008]. In conclusion, GLP1R missense variant was associated with a reduced response to gliptin treatment. The genotype-related effect size of â¼0.7% (8 mmol/mol) is equal to an average effect of gliptin treatment and makes this variant a candidate for use in precision medicine.
Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Inibidores da Dipeptidil Peptidase IV/uso terapêutico , Receptor do Peptídeo Semelhante ao Glucagon 1/genética , Receptores dos Hormônios Gastrointestinais/genética , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/metabolismo , Feminino , Genótipo , Hemoglobinas Glicadas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Mutação de Sentido Incorreto , Variantes Farmacogenômicos , Projetos Piloto , Medicina de Precisão , Reação em Cadeia da Polimerase em Tempo Real , Resultado do TratamentoRESUMO
BACKGROUND AND OBJECTIVES: Autoimmune thyroid diseases are frequent in patients with type 1 diabetes mellitus. The aim of our study was to determine the incidence of autoimmune thyroid diseases (AIT) in the different groups of patients with DM (DM type 1--classical form, DM type 1--subtype LADA, DM type 2) and compare the incidence of AIT among the groups as well as to the control group of non-diabetics. We also focused our attention on the factors that influence the risk of thyroid diseases incidence in diabetics. PATIENTS AND METHODS: We examined 79 diabetics (38 women and 41 men, x = 55.4 +/- 2.8). Diabetic patients were divided into three groups. The control group consisted of 30 non-diabetics. RESULTS: Chronic autoimmune thyroiditis was diagnosed in 8 (40%) patients in the first group, in 6 (50%) in the 2nd group of patients and finally in 20 (43%) patients with type 2 diabetes mellitus--3rd group. A significantly higher prevalence of chronic autoimmune thyroiditis was observed in female diabetics and in diabetics with positive family history of thyroid diseases. CONCLUSION: Results of paper confirm an increased prevalence of chronic autoimmune thyroiditis in patients with all types of diabetes mellitus resulting in recommendation of careful follow-up of all diabetic patients for presence of thyroid autoimmunity (Tab. 5, Ref, 13). Full Text (Free, PDF) www.bmj.sk.
Assuntos
Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 2/complicações , Tireoidite Autoimune/complicações , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tireoidite Autoimune/diagnósticoRESUMO
Autoimmune thyropathies are frequent in patients with type 1 diabetes mellitus. Some recently published papers confirm similarly high prevalence of autoimmune thyropathies also in patients with type 2 diabetes mellitus. Chronic autoimmune thyroiditis is the most frequent form of autoimmune thyropathies. Authors examined 79 accidentally selected diabetics (38 women and 41 men, x = 55.4 +/- 2.8). Diabetic patients were divided into three groups. 20 patients with type 1 diabetes mellitus - classical form were the first group, 12 patients with LADA were the second group and 47 patients with type 2 diabetes mellitus constituted the third group. Authors diagnosed chronic autoimmune thyroiditis in 8 (40 %) patients in the group of patients with type 1 diabetes mellitus, in 6 (50%) in the group of patients with LADA and in 20 (43%) of patients with type 2 diabetes mellitus. They didn't find out statistically more frequent prevalence of chronic autoimmune thyroiditis in all groups of patients with diabetes (patients with type 1 diabetes mellitus, patients with LADA, patients with type 2 diabetes mellitus) in comparison with control group of non-diabetic subjects. They found out statistically significant more frequent prevalence of chronic autoimmune thyroiditis in diabetics of woman gender and in diabetics with positive family history of thyropathies. Results of paper confirm recommendation of examining once or twice a year autoantibodies against thyroid gland and level of thyrotropin (TSH) with the aim of early finding of laboratory manifestation of thyroidal autoimmunity or developing functional disorder.